Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.022 | 0.7 |
mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |